ProSomnus, Inc. (OSA)
NASDAQ
Healthcare
Medical - Devices
$0.47
▲ +0.00%
Market Cap
$8.2M
Sector
Healthcare
Industry
Medical - Devices
Beta
0.21
52-Wk Range
0.47-0.5
CEO
Leonard Liptak
Country
US
Currency
USD
ProSomnus, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Pleasanton, CA, US. The stock last traded at $0.47, up 0.00% on the session, giving a market capitalisation of $8.2M. On trailing twelve-month figures it carries a trailing P/E of -0.32, a net margin of -87.1%. Its beta of 0.21 implies it has historically moved less than the broad market.
Valuation & profitability (TTM)
P/E
-0.32
Price / Sales
0.30
Price / Book
-0.29
EV / EBITDA
-2.40
Gross margin
50.7%
Operating margin
-69.1%
Net margin
-87.1%
Return on equity
—
Debt / equity
-1.56
Current ratio
1.00
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Global Market
Employees
136
IPO date
2021-07-28
Headquarters
Pleasanton, CA, US
About ProSomnus, Inc.
ProSomnus, Inc. develops and provides specialized oral appliance therapy solutions crafted to alleviate obstructive sleep apnea (OSA). This enterprise, which originated in 2016, maintains its headquarters in Pleasanton, California.
Comparable companies
ProSomnus, Inc. is most often compared with the following Healthcare names:
More research on OSA
Open full interactive analysis & DCF →